title: VEGF-A and VEGF-Ax: bad protein and good protein.
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario, Valladolid, España. Electronic address: victor_asensio@orangemail.es.
authors.forename: V M
authors.initials: VM
authors.lastname: Asensio-Sánchez
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000068258:Bevacizumab / Q000494:pharmacology / Q000627:therapeutic use; D018388:Codon, Terminator; D015195:Drug Design; D006801:Humans; D058990:Molecular Targeted Therapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D014176:Protein Biosynthesis; D020033:Protein Isoforms / Q000737:chemistry / Q000494:pharmacology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000737:chemistry* / Q000235:genetics / Q000494:pharmacology
chemical_list: D020533:Angiogenesis Inhibitors; D018388:Codon, Terminator; D020033:Protein Isoforms; C000613307:VEGF-Ax protein, human; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab